The Microbiome Business & Science Briefing
MicrobimeTimes
Reporting on The Latest Microbiome Business & Scientific Developments
TRENDING
MaaT Pharma Provides Update on MaaT013 (Xervyteg®) Potential Development Plan Following CHMP Negative Opinion After Re-examination• Evvy Raises $40M Series B to Scale AI-Powered Precision Diagnostics & Care Platform for Women’s Health• Armata Pharmaceuticals Receives U.S. FDA Breakthrough Therapy Designation for AP-SA02• GutAlive®: Microbiota Collection and Transport in Anaerobic Conditions• From Discovery to Disease Prevention: How the Biose–Siolta Partnership is Advancing a New Generation of Live Biotherapeutics• A pioneering gut bacterium passes Europe’s food-safety review under the EU Novel Food Regulation•

Microbiome Times

Scientists find gut-brain link that may affect behavior in children with autism
Gastrointestinal

Scientists find gut-brain link that may affect behavior in children with autism

APR 25, 2025
Some gut bacteria could make certain drugs less effective
Pharma & Human Health

Some gut bacteria could make certain drugs less effective

APR 16, 2025
Mental Health and the Brain-Gut-Microbiota Axis: Fundamental Importance of Diet
Editor's Choice

Mental Health and the Brain-Gut-Microbiota Axis: Fundamental Importance of Diet

APR 3, 2025
New study sheds light on how bacteria ‘vaccinate’ themselves with genetic material from dormant viruses
Pharma & Human Health

New study sheds light on how bacteria ‘vaccinate’ themselves with genetic material from dormant viruses

MAR 27, 2025
Novel In vitro Model Replicates Intestinal Microbiota Composition Without Requiring Anaerobic Incubation
Editor's Choice

Novel In vitro Model Replicates Intestinal Microbiota Composition Without Requiring Anaerobic Incubation

MAR 25, 2025
PepsiCo to Acquire fast-growing prebiotic soda brand for $1.95 billion
Finance

PepsiCo to Acquire fast-growing prebiotic soda brand for $1.95 billion

MAR 21, 2025
Bloom Science Demonstrates Durable Weight Loss in Overweight Individuals in Phase 1 Trial of BL-001 
Clinical & Manufacturing

Bloom Science Demonstrates Durable Weight Loss in Overweight Individuals in Phase 1 Trial of BL-001 

MAR 7, 2025
Dynamic Microbiome Abundance Profiling: A new tool to solve challenges in microbiome analysis
Editor's Choice

Dynamic Microbiome Abundance Profiling: A new tool to solve challenges in microbiome analysis

MAR 5, 2025
Synthetic microbiome therapy suppresses bacterial infection without antibiotics
Infectious Disease & AMR

Synthetic microbiome therapy suppresses bacterial infection without antibiotics

MAR 5, 2025
BiomX Announces a Series of Financings for Aggregate Gross Proceeds of $12 Million
Finance

BiomX Announces a Series of Financings for Aggregate Gross Proceeds of $12 Million

FEB 26, 2025
Scientists decode diet from stool DNA – no questions asked
Editor's Choice

Scientists decode diet from stool DNA – no questions asked

FEB 24, 2025